Drug Price Controls and Their Unintended Effects

Estimates suggest that the United States comprises up to 80% of total global medical innovation. This is because the U.S. has a unique lack of price regulation on drugs, allowing pharmaceutical companies to thrive. However, leaders across the political spectrum including Clinton, Sanders, and Trump have been proposing the implementation of price controls on the pharmaceutical industry to slow rising drug prices.